GB Sciences, Inc. (GBLX)

OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Mar 9, 2026, 3:05 PM EST
0.00%
Market Cap 153.72K
Revenue (ttm) 97.24K
Net Income (ttm) -1.06M
Shares Out 512.41M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,222
Average Volume 25,060
Open 0.0003
Previous Close 0.0003
Day's Range 0.0003 - 0.0003
52-Week Range 0.0000 - 0.5002
Beta 11.70
RSI 37.62
Earnings Date Feb 6, 2026

About GB Sciences

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Scie... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol GBLX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.